Mike Pollastri

Sponsor: NIH/NIAID

In partnership with Drugs for Neglected Diseases initiative (R21AI141227), and with collaborators at CSIC (Granada, Spain; R01AI114685) and Kennesaw State University (R01AI124046), we will repurpose human kinase inhibitors as treatments for the parasitic diseases leishmaniasis, Chagas disease and human African trypanosomiasis.